These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross-sectional study from a single center in China. Zhao L; Ren G; Fan R; Feng X; Liu Z; Cheng Z; Zhang T Clin Exp Med; 2022 Nov; 22(4):629-635. PubMed ID: 34698949 [TBL] [Abstract][Full Text] [Related]
4. Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Greenstein AJ; Sachar DB; Panday AK; Dikman SH; Meyers S; Heimann T; Gumaste V; Werther JL; Janowitz HD Medicine (Baltimore); 1992 Sep; 71(5):261-70. PubMed ID: 1522802 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases. Pan Y; Lilly E; Ananthakrishnan AN Dig Dis Sci; 2024 Sep; 69(9):3375-3381. PubMed ID: 39078458 [TBL] [Abstract][Full Text] [Related]
7. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697 [TBL] [Abstract][Full Text] [Related]
8. Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score-matched analysis of US nationwide inpatient sample 2016-2018. Zheng WW; Zhou Q; Xue ML; Yu X; Chen JT; Ao L; Wang CD J Dig Dis; 2023 Nov; 24(11):572-583. PubMed ID: 37823607 [TBL] [Abstract][Full Text] [Related]
9. Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era. Dincer MT; Dincer ZT; Bakkaloglu OK; Yalin SF; Trabulus S; Celik AF; Seyahi N; Altiparmak MR Med Sci Monit; 2022 Jul; 28():e936497. PubMed ID: 35791280 [TBL] [Abstract][Full Text] [Related]
10. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study. Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500 [TBL] [Abstract][Full Text] [Related]
11. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome. Serra I; Oller B; Mañosa M; Naves JE; Zabana Y; Cabré E; Domènech E J Crohns Colitis; 2010 Sep; 4(3):269-74. PubMed ID: 21122515 [TBL] [Abstract][Full Text] [Related]
12. Microscopic colitis in patients with ulcerative colitis or Crohn's disease: a retrospective observational study and review of the literature. Wickbom A; Bohr J; Nyhlin N; Eriksson A; Lapidus A; Münch A; Ung KA; Vigren L; Öst Å; Tysk C; Scand J Gastroenterol; 2018 Apr; 53(4):410-416. PubMed ID: 29546806 [TBL] [Abstract][Full Text] [Related]
13. Aplastic anemia associated with Crohn's disease: a tertiary center retrospective study. Su S; Liu Z; Wang F; Zhang Y; Chu Y; Jiang M; Xu B; Wu N; Lin J; Xue X; Shi Y; Yang S; Wu K; Liang J Ann Hematol; 2019 Sep; 98(9):2053-2061. PubMed ID: 31256218 [TBL] [Abstract][Full Text] [Related]
14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
15. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Wester AL; Vatn MH; Fausa O Inflamm Bowel Dis; 2001 Nov; 7(4):295-300. PubMed ID: 11720318 [TBL] [Abstract][Full Text] [Related]
16. Bilateral renal artery embolization in a case with severe proteinuria secondary to amyloidosis in a hemodialysis patient. Turgut F; Kanbay M; Kaya A; Uz B; Akcay A Amyloid; 2007 Jun; 14(2):157-8. PubMed ID: 17577690 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross-sectional imaging in a tertiary care setting. Vuyyuru SK; Solitano V; Aruljothy A; Alkhattabi M; Beaton M; Gregor J; Kassam Z; Marshall H; Ramsewak D; Sedano R; Sey M; Jairath V United European Gastroenterol J; 2024 Sep; 12(7):870-878. PubMed ID: 39074035 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and survival in AA amyloidosis patients. Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691 [TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Sofia MA; Rubin DT; Hou N; Pekow J Dig Dis Sci; 2014 Sep; 59(9):2228-35. PubMed ID: 24752402 [TBL] [Abstract][Full Text] [Related]
20. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea. Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]